middle.news
Island Pharmaceuticals Secures $9M to Propel Galidesivir Toward FDA Approval
9:42am on Wednesday 4th of February, 2026 AEDT
•
Pharmaceuticals
Read Story
Island Pharmaceuticals Secures $9M to Propel Galidesivir Toward FDA Approval
9:42am on Wednesday 4th of February, 2026 AEDT
Key Points
Raised $9 million via placement of 25.7 million shares at $0.35 each
Funding to complete Galidesivir’s FDA Animal Rule development and NDA submission
Placement led by US-based family office with local and international investors
Capital supports manufacturing and regulatory work for Ebola and Sudan virus programs
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE